Current status of the research and development of new formulations and drugs for cystic echinococcosis
10.3969/j.issn.1001-5256.2019.04.045
- VernacularTitle:囊型包虫病药物新剂型研发及新药开发现状
- Author:
Jie YIN
1
;
Haining FAN
;
Hao WEN
Author Information
1. Graduate School of Qinghai University, Xining 810000, China
- Publication Type:Research Article
- Keywords:
echinococcosis, hepatic;
pharmaceutical preparations;
review
- From:
Journal of Clinical Hepatology
2019;35(4):908-912
- CountryChina
- Language:Chinese
-
Abstract:
Cystic echinococcosis (CE) is a zoonotic parasitic disease caused by Echinococcus granulosus infection and can involve the organs in the whole body. Surgery is the primary method for the treatment of CE. With the development of related techniques, precision operation, and no-tumor operation standards, more and more patients are able to receive surgical treatment, but there are still many patients who can only receive drug conservative treatment. However, there are limited drugs for the treatment of CE at present, and only benzimidazole has a definite therapeutic effect. This article reviews the research advances in the pharmacotherapy for CE in China and foreign countries, so as to provide a reference for drug research and development and clinical drug use.
